These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38778568)

  • 1. Use of neurofilament light chain to identify structural brain diseases in dogs.
    Sung J; Chae Y; Yun T; Koo Y; Lee D; Kim H; Yang MP; Kang BT
    J Vet Intern Med; 2024; 38(4):2196-2203. PubMed ID: 38778568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs.
    Yun T; Koo Y; Chae Y; Lee D; Kim H; Kim S; Chang D; Na KJ; Yang MP; Kang BT
    J Vet Intern Med; 2021 Jul; 35(4):1865-1872. PubMed ID: 34114244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neurofilament light chain as a biomarker in dogs with structural and idiopathic epilepsy.
    Fowler KM; Shinn RL; Rossmeisl JH; Parker RL
    J Vet Intern Med; 2024; 38(3):1577-1582. PubMed ID: 38509606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the blood neutrophil-to-lymphocyte ratio as a biomarker for meningoencephalitis of unknown etiology in dogs.
    Park J; Lee D; Yun T; Koo Y; Chae Y; Kim H; Yang MP; Kang BT
    J Vet Intern Med; 2022 Sep; 36(5):1719-1725. PubMed ID: 35929724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between neurofilament light chain concentration and lesion size in dogs with meningoencephalitis of unknown origin.
    Yun T; Koo Y; Chae Y; Lee D; Kim H; Yang MP; Kang BT
    Vet Med Sci; 2023 Jul; 9(4):1541-1546. PubMed ID: 37248819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.
    Disanto G; Prosperetti C; Gobbi C; Barro C; Michalak Z; Cassina T; Kuhle J; Casso G; Agazzi P
    Epilepsy Behav; 2019 Dec; 101(Pt B):106432. PubMed ID: 31375414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in Dogs.
    Panek WK; Gruen ME; Murdoch DM; Marek RD; Stachel AF; Mowat FM; Saker KE; Olby NJ
    Mol Neurobiol; 2020 Jul; 57(7):3143-3149. PubMed ID: 32472519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between cerebrospinal fluid and serum lactate concentrations in neurologic dogs with and without structural intracranial disease.
    Benedicenti L; Gianotti G; Galban EM
    Can J Vet Res; 2018 Apr; 82(2):97-101. PubMed ID: 29755188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
    Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J
    Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light as a biomarker in traumatic brain injury.
    Shahim P; Politis A; van der Merwe A; Moore B; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Gill JM; Brody DL; Zetterberg H; Blennow K; Chan L
    Neurology; 2020 Aug; 95(6):e610-e622. PubMed ID: 32641538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
    Liu HC; Lin WC; Chiu MJ; Lu CH; Lin CY; Yang SY
    PLoS One; 2020; 15(6):e0234519. PubMed ID: 32530970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
    Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
    J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
    Lewczuk P; Ermann N; Andreasson U; Schultheis C; Podhorna J; Spitzer P; Maler JM; Kornhuber J; Blennow K; Zetterberg H
    Alzheimers Res Ther; 2018 Jul; 10(1):71. PubMed ID: 30055655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.